NCNA
NuCana plc

7,890
Loading...
Loading...
News
all
press releases
NuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
NuCana presented final data from a Phase 2 study at ESMO Congress, showing NUC-7738 combined with Keytruda achieved a 75% disease control rate in metastatic melanoma patients resistant to prior PD-1...
Benzinga·1y ago
News Placeholder
More News
News Placeholder
NuCana Stock Plunges On Colorectal Combo Therapy Trial Setback, Ends Mid-Stage Study After Disappointing Data
NuCana will discontinue the NuTide:323 study after an initial analysis recommended by the Steering Committee, as the combination treatment was unlikely to achieve superior Progression-Free Survival...
Benzinga·1y ago
News Placeholder
NuCana plc (NASDAQ:NCNA) Sees Significant Growth in Short Interest
NuCana plc (NASDAQ:NCNA Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,480,000...
Zolmax·1y ago
News Placeholder
Why NuCana (NCNA) Shares Are Trading Lower
NuCana shares are trading lower by 16.6% during Thursday's session. The company late Wednesday said it intends to adjust the ratio of its American Depository Shares (ADSs). read more...
Benzinga·1y ago
News Placeholder
Truist Financial Sticks to Its Buy Rating for Nucana (NCNA)
In a report released today, Robyn Karnauskas from Truist Financial maintained a Buy rating on Nucana (NCNA Research Report). The company's shares...
TipRanks Financial Blog·1y ago
News Placeholder
NuCana Announces Plan to Implement ADS Ratio Change
EDINBURGH, United Kingdom, March 27, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced plans to change the ratio of its American Depository Shares ( ADSs ) to its ordinary shares from...
Globe Newswire·1y ago
News Placeholder
Short Interest in NuCana plc (NASDAQ:NCNA) Expands By 2,616.3%
NuCana plc (NASDAQ:NCNA Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,480,000...
Ticker Report·1y ago
News Placeholder
William Blair Comments on NuCana plc's FY2024 Earnings (NASDAQ:NCNA)
NuCana plc (NASDAQ:NCNA Free Report) Stock analysts at William Blair issued their FY2024 EPS estimates for NuCana in a research note issued to investors on Thursday, March 21st...
Zolmax·1y ago
News Placeholder
NuCana GAAP EPS of -?0.14
NuCana GAAP EPS of -?0.14...
SeekingAlpha.com: All News·1y ago
News Placeholder
NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update
Announced Encouraging Updates from NUC-3373 and NUC-7738 Demonstrating Promising Efficacy and Safety Pipeline Continues to Advance with Key Data Readouts Expected for All Programs in 2024...
Globe Newswire·1y ago

Latest NCNA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.